Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2026
  • Volume: 19
  • Issue: 5

Synthesis, Develop and Characterization of New Quinoline-Sulfonamides derivatives as Specific Tumer-Related CARBONIC ANHYDRASE Isoform XII Inhibitors

  • Author:
  • Bayan Bahnasli1,*, Djamila Ben Hadda2,**, Amir Balash3,***, Mustapha Fawaz Chehna1,****
  • Total Page Count: 7
  • Page Number: 2121 to 2127

1Department of Pharmaceutical Chemistry & Drug Control, Faculty of Pharmacy, Aleppo University, Aleppo, Syria

2Department of Pharmaceutical Chemistry & Drug Control, Faculty of Pharmacy, Ebla University, Aleppo, Syria

3Department of Pharmaceutical Chemistry & Drug Control, Faculty of Pharmacy, Philipps University, Marburg, Germany

*Corresponding Author E-mail: bbahnasli@gmail.com

**djamila.benhadda@ebla.edu.sy

***amir_balash@hotmail.com

****mf.chehna@gmail.com

Abstract

Numerous studies highlight the significant responsibility of CARBONIC ANHYDRASE Isoform XII in the mechanisms underlying the onset and progression of cancer. Our research focuses on the synthesis of Quinoline-Sulfonamides, which are compounds designed to inhibit this enzyme, a key player in cancer development. Using Molegro Virtual Docker (MVD), we conducted molecular modeling of these compounds, targeting Carbonic Anhydrase Isoform XII, and calculated their binding energies to identify the most promising candidate. Among the compounds studied, compound 1..e exhibited the highest binding energy at -166.694kcal/mol in comparison to 4-propylthiobenzen sulfonamide (VD9), Which has a binding energy of -115kcal/mol , Several of these compounds were synthesized efficiently using an economical and environmentally friendly aqueous method with high yield ranging between 70 to 86%.Their physicochemical properties were studied using Marvin Sketch and structural identification were confirmed through different analytical methods, involving Mass Spectrography, Infrared Spectrography, and nuclear magnetic resonance.

Keywords

CA XII enzyme, Sulfonamide-quinoline derivatives, Quinoline-8-sulfonyl chloride, Arbonic Anhydrase XII, Hypoxia